by Ben Green | Jun 26, 2024
The rare cancer research landscape has made remarkable progress over the past 15 years. Since its inception, TargetCancer Foundation has played a significant role in driving this progress forward through innovative rare cancer research initiatives. This short video...
by Ben Green | May 21, 2024
When Paul Poth was diagnosed with cholangiocarcinoma at 38 years old, he was told that there were no treatment options available and little research being carried out, because his cancer was rare. He wanted to change this, and started TargetCancer Foundation in 2009....